• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于参数化等待时间分布确定处方持续时间。

Determining prescription durations based on the parametric waiting time distribution.

作者信息

Støvring Henrik, Pottegård Anton, Hallas Jesper

机构信息

Biostatistics, Department of Public Health, Aarhus University, Aarhus, Denmark.

Clinical Pharmacology, Department of Public Health, University of Southern Denmark, Odense, Denmark.

出版信息

Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1451-1459. doi: 10.1002/pds.4114. Epub 2016 Sep 26.

DOI:10.1002/pds.4114
PMID:27670969
Abstract

PURPOSE

The purpose of the study is to develop a method to estimate the duration of single prescriptions in pharmacoepidemiological studies when the single prescription duration is not available.

METHODS

We developed an estimation algorithm based on maximum likelihood estimation of a parametric two-component mixture model for the waiting time distribution (WTD). The distribution component for prevalent users estimates the forward recurrence density (FRD), which is related to the distribution of time between subsequent prescription redemptions, the inter-arrival density (IAD), for users in continued treatment. We exploited this to estimate percentiles of the IAD by inversion of the estimated FRD and defined the duration of a prescription as the time within which 80% of current users will have presented themselves again. Statistical properties were examined in simulation studies, and the method was applied to empirical data for four model drugs: non-steroidal anti-inflammatory drugs (NSAIDs), warfarin, bendroflumethiazide, and levothyroxine.

RESULTS

Simulation studies found negligible bias when the data-generating model for the IAD coincided with the FRD used in the WTD estimation (Log-Normal). When the IAD consisted of a mixture of two Log-Normal distributions, but was analyzed with a single Log-Normal distribution, relative bias did not exceed 9%. Using a Log-Normal FRD, we estimated prescription durations of 117, 91, 137, and 118 days for NSAIDs, warfarin, bendroflumethiazide, and levothyroxine, respectively. Similar results were found with a Weibull FRD.

CONCLUSIONS

The algorithm allows valid estimation of single prescription durations, especially when the WTD reliably separates current users from incident users, and may replace ad-hoc decision rules in automated implementations. Copyright © 2016 John Wiley & Sons, Ltd.

摘要

目的

本研究的目的是开发一种方法,用于在无法获得单张处方持续时间时,在药物流行病学研究中估计单张处方的持续时间。

方法

我们基于等待时间分布(WTD)的参数化双组分混合模型的最大似然估计开发了一种估计算法。现患使用者的分布成分估计向前复发密度(FRD),其与后续处方取药之间的时间分布相关,即持续治疗使用者的到达间隔密度(IAD)。我们利用这一点通过估计的FRD的反演来估计IAD的百分位数,并将处方持续时间定义为80%的当前使用者再次就诊的时间范围。在模拟研究中检验了统计特性,并将该方法应用于四种模型药物的经验数据:非甾体抗炎药(NSAIDs)、华法林、苄氟噻嗪和左甲状腺素。

结果

模拟研究发现,当IAD的数据生成模型与WTD估计中使用的FRD(对数正态分布)一致时,偏差可忽略不计。当IAD由两个对数正态分布的混合组成,但用单个对数正态分布进行分析时,相对偏差不超过9%。使用对数正态FRD,我们分别估计NSAIDs、华法林、苄氟噻嗪和左甲状腺素的处方持续时间为117天、91天、137天和118天。使用威布尔FRD也得到了类似的结果。

结论

该算法能够有效估计单张处方的持续时间,特别是当WTD可靠地将现患使用者与新发病使用者区分开时,并且可以在自动化实施中取代临时决策规则。版权所有©2016约翰威立父子有限公司。

相似文献

1
Determining prescription durations based on the parametric waiting time distribution.基于参数化等待时间分布确定处方持续时间。
Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1451-1459. doi: 10.1002/pds.4114. Epub 2016 Sep 26.
2
Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution.利用药物流行病学数据库中的观察协变量优化处方持续时间估计:反向等待时间分布的应用
Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):900-908. doi: 10.1002/pds.4216. Epub 2017 May 3.
3
Estimating medication stopping fraction and real-time prevalence of drug use in pharmaco-epidemiologic databases. An application of the reverse waiting time distribution.在药物流行病学数据库中估计停药比例和药物使用的实时流行率。反向等待时间分布的应用。
Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):909-916. doi: 10.1002/pds.4217. Epub 2017 May 4.
4
Assigning exposure duration to single prescriptions by use of the waiting time distribution.利用等待时间分布为单次处方分配暴露持续时间。
Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):803-9. doi: 10.1002/pds.3459. Epub 2013 May 23.
5
Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling.利用具有随机索引日期的等待时间分布来估算存在季节性囤药情况下的处方持续时间。
Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1072-1078. doi: 10.1002/pds.5026. Epub 2020 May 21.
6
Empirical validation of the reverse parametric waiting time distribution and standard methods to estimate prescription durations for warfarin.华法林反向参数等待时间分布及估计处方持续时间标准方法的实证验证。
Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1011-1018. doi: 10.1002/pds.4581. Epub 2018 Jun 28.
7
Comparative evaluation of methods approximating drug prescription durations in claims data: modeling, simulation, and application to real data.医保理赔数据中药物处方持续时间近似方法的比较评估:建模、模拟及实际数据应用
Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1434-1442. doi: 10.1002/pds.4091. Epub 2016 Sep 16.
8
A new likelihood model for analyses of pharmacoepidemiologic case-control studies which avoids decision rules for determining latent exposure status.一种新的可能性模型,用于分析药物流行病学病例对照研究,避免了用于确定潜在暴露状态的决策规则。
BMC Med Res Methodol. 2021 Jul 8;21(1):144. doi: 10.1186/s12874-021-01312-y.
9
Using multiple random index dates with the reverse waiting time distribution improves precision of estimated prescription durations.使用具有反向等待时间分布的多个随机索引日期可以提高估计处方持续时间的精度。
Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1727-1734. doi: 10.1002/pds.5340. Epub 2021 Sep 3.
10
Prescription duration and treatment episodes in oral glucocorticoid users: application of the parametric waiting time distribution.口服糖皮质激素使用者的处方持续时间和治疗疗程:参数等待时间分布的应用
Clin Epidemiol. 2017 Nov 16;9:591-600. doi: 10.2147/CLEP.S148671. eCollection 2017.

引用本文的文献

1
Estimation of the Duration of Antihypertensive Prescriptions: Validation of a Data-Driven Approach Using Rotterdam Study Data.抗高血压处方持续时间的估计:使用鹿特丹研究数据对数据驱动方法的验证
Pharmacoepidemiol Drug Saf. 2025 Jun;34(6):e70164. doi: 10.1002/pds.70164.
2
Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study.巴罗昔单抗危害评估方法:一项多中心观察性安全性研究(BRAHMS)。
BMJ Open. 2023 Feb 1;13(2):e066057. doi: 10.1136/bmjopen-2022-066057.
3
Automatic Estimation of the Most Likely Drug Combination in Electronic Health Records Using the Smooth Algorithm: Development and Validation Study.
使用平滑算法自动估计电子健康记录中最可能的药物组合:开发与验证研究
JMIR Med Inform. 2022 Nov 15;10(11):e37976. doi: 10.2196/37976.
4
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual-level drug dispensing data.药物流行病学的核心概念:基于个体药物配药数据的药物利用测量方法。
Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1015-1026. doi: 10.1002/pds.5490. Epub 2022 Aug 11.
5
Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources.使用二次数据源计算药物处方持续时间的数据驱动方法的原理和性能。
Sci Rep. 2022 Apr 15;12(1):6245. doi: 10.1038/s41598-022-10144-9.
6
A flexible mixed-data model applied to claims data for post-market surveillance of prescription drug safety behavior.一种应用于上市后药物安全性行为监测的索赔数据的灵活混合数据模型。
Pharm Stat. 2022 Sep;21(5):1022-1036. doi: 10.1002/pst.2213. Epub 2022 Apr 3.
7
Incidence in pharmacoepidemiology-Basic definitions and types of misclassification.药物流行病学中的发生率-基本定义和分类错误类型。
Basic Clin Pharmacol Toxicol. 2022 Jun;130(6):632-643. doi: 10.1111/bcpt.13727. Epub 2022 Apr 13.
8
Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries.基于北欧健康登记处的研究:医疗保健系统与关键登记处综述
Clin Epidemiol. 2021 Jul 19;13:533-554. doi: 10.2147/CLEP.S314959. eCollection 2021.
9
Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources.利用二级数据源计算药物处方持续时间的药物流行病学方法。
Eur J Clin Pharmacol. 2021 Dec;77(12):1805-1814. doi: 10.1007/s00228-021-03188-9. Epub 2021 Jul 10.
10
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study.非维生素 K 拮抗剂口服抗凝剂和华法林在心房颤动中的有效性和安全性:一项斯堪的纳维亚基于人群的队列研究。
Eur Heart J Qual Care Clin Outcomes. 2022 Aug 17;8(5):577-587. doi: 10.1093/ehjqcco/qcab048.